Using AI to help physicians diagnose rare genetic diseases affecting children
Researchers used an OpenAI reasoning model to help diagnose rare diseases, identifying 18 new diagnoses in previously unsolved cases.
Geneticist Catherine Brownstein demonstrates how OpenAI o1 can speed up the process of diagnosing rare medical challenges.
Researchers used an OpenAI reasoning model to help diagnose rare diseases, identifying 18 new diagnoses in previously unsolved cases.
Boston Children’s Hospital uses OpenAI technology to improve patient care, reduce operational burden, and help diagnose more than 40 rare disease cases.
Color Health is working with OpenAI to pioneer a new way of accelerating cancer patients’ access to treatment. Their new Cancer Copilot application uses GPT-4o to identify missing diagnostics and create tailored workup plans, enabling healthcare providers to make evidence-based decisions about cancer screening and treatment.
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Paradigm uses OpenAI’s API to improve patient access to clinical trials.
OpenAI introduces a real-world evaluation framework to measure how AI can accelerate biological research in the wet lab. Using GPT-5 to optimize a molecular cloning protocol, the work explores both the promise and risks of AI-assisted experimentation.
arXiv:2606. 24779v1 Announce Type: cross Abstract: Birth defects are a major cause of fetal loss, neonatal morbidity and long-term disability.
OpenAI for Healthcare enables secure, enterprise-grade AI that supports HIPAA compliance—reducing administrative burden and supporting clinical workflows.
OpenAI o1 Contributions
OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.